Cargando…

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

BACKGROUND: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candidate antigen, known to elicit protective antibody responses in humans (RTS,S vaccine). Recently, a DNA prime / adenovirus (Ad) vector boost vaccine encoding CSP and a second P. falciparum antigen, apic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedegah, Martha, Kim, Yohan, Ganeshan, Harini, Huang, Jun, Belmonte, Maria, Abot, Esteban, Banania, Jo Glenna, Farooq, Fouzia, McGrath, Shannon, Peters, Bjoern, Sette, Alessandro, Soisson, Lorraine, Diggs, Carter, Doolan, Denise L, Tamminga, Cindy, Villasante, Eileen, Hollingdale, Michael R, Richie, Thomas L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683343/ https://www.ncbi.nlm.nih.gov/pubmed/23738590 http://dx.doi.org/10.1186/1475-2875-12-185

Ejemplares similares

Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
por: Sedegah, Martha, et al.
Publicado: (2010)

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming
por: Sedegah, Martha, et al.
Publicado: (2015)

Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
por: Sedegah, Martha, et al.
Publicado: (2014)

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
por: Tamminga, Cindy, et al.
Publicado: (2011)

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
por: Sedegah, Martha, et al.
Publicado: (2011)

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria
por: Ganeshan, Harini, et al.
Publicado: (2016)

IMRAS—Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS
por: Sedegah, Martha, et al.
Publicado: (2021)

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
por: Tamminga, Cindy, et al.
Publicado: (2013)

Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
por: Sedegah, Martha, et al.
Publicado: (2016)

Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
por: Sedegah, Martha, et al.
Publicado: (2016)

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
por: Chuang, Ilin, et al.
Publicado: (2013)

Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population
por: Kusi, Kwadwo A., et al.
Publicado: (2020)

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8(+) T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1
por: Schwenk, Robert, et al.
Publicado: (2013)

Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults
por: Anum, Dorothy, et al.
Publicado: (2015)

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
por: Dodoo, Daniel, et al.
Publicado: (2011)

IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents
por: Hickey, Bradley, et al.
Publicado: (2020)

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
por: Sklar, Marvin J., et al.
Publicado: (2021)

Comparison of the impact of allelic polymorphisms in PfAMA1 on the induction of T Cell responses in high and low malaria endemic communities in Ghana
por: Ofori, Ebenezer A., et al.
Publicado: (2021)

Comparative analysis of the ex vivo IFN-gamma responses to CD8+ T cell epitopes within allelic forms of PfAMA1 in subjects with natural exposure to malaria
por: Nlinwe, Omarine N., et al.
Publicado: (2021)

Putative circumsporozoite protein (CSP) of Plasmodium vivax is considerably distinct from the well-known CSP and plays a role in the protein ubiquitination pathway
por: Dash, Manoswini, et al.
Publicado: (2019)

In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
por: Livingstone, Merricka C., et al.
Publicado: (2021)

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA
por: Richie, Thomas L., et al.
Publicado: (2012)

Evolutionary analysis of circumsporozoite surface protein and merozoite surface protein-1 (CSP and MSP-1) sequences of malaria parasites
por: Tripathi, Vijay, et al.
Publicado: (2011)

Genotyping and Phylogenetic Analysis of Plasmodium vivax Circumsporozoite Protein (PvCSP) Gene of Clinical Isolates in South-Eastern Iran
por: ETEMADI, Soudabeh, et al.
Publicado: (2020)

CHARM: COVID-19 Health Action Response for Marines–Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test
por: Sedegah, Martha, et al.
Publicado: (2022)

Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization
por: Jiang, George, et al.
Publicado: (2007)

Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior
por: Kim, Yohan, et al.
Publicado: (2009)

Positional Bias of MHC Class I Restricted T-Cell Epitopes in Viral Antigens Is Likely due to a Bias in Conservation
por: Kim, Yohan, et al.
Publicado: (2013)

Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions
por: Kim, Yohan, et al.
Publicado: (2014)

New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
por: Limbach, Keith, et al.
Publicado: (2017)

Polymorphisms in Plasmodium vivax Circumsporozoite Protein (CSP) Influence Parasite Burden and Cytokine Balance in a Pre-Amazon Endemic Area from Brazil
por: Ribeiro, Bruno de Paulo, et al.
Publicado: (2016)

Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon
por: Pratt-Riccio, Lilian Rose, et al.
Publicado: (2019)

Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)
por: Parums, Dinah V.
Publicado: (2021)

ReverCSP: Time-Travelling in CSP Computations
por: Galindo, Carlos, et al.
Publicado: (2020)

Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates
por: Limbach, Keith, et al.
Publicado: (2011)

Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
por: Nateghpour, Mehdi, et al.
Publicado: (2021)

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity
por: Hickey, Bradley W., et al.
Publicado: (2016)

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
por: de Camargo, Tarsila Mendes, et al.
Publicado: (2018)

A computational pipeline to generate MHC binding motifs
por: Wang, Peng, et al.
Publicado: (2011)

Evaluating the Immunogenicity of Protein Drugs by Applying In Vitro MHC Binding Data and the Immune Epitope Database and Analysis Resource
por: Paul, Sinu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t9k44t5u07ca6bjfe3dfnb1v2c